BioCatalyst

VSTM — Verastem, Inc. catalysts

1 verified catalyst event(s) for Verastem, Inc. (ticker VSTM). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-08-31 — Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patient · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08-31
in 2mo
ESTIMATED
 READOUT
Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel
Phase 1/2 · KRAS Activating Mutation, Metastatic Cancer
 VSTM Verastem, Inc. avutometinib (VS-6766) and defactinib in ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.